Denison Kuruvilla

Denison Kuruvilla

Genentech, Inc - South San Francisco / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5619122
-
person_outline Denison Kuruvilla's MOST POPULAR ARTICLES
1-) Phase I study of MEDI3617, a selective angiopoietin-2 inhibitor alone and combined with carboplatin/paclitaxel, paclitaxel, or bevacizumab for advanced solid tumorsDM Hyman, N Rizvi, R Natale, DK Armstrong, M Birrer, L Recht, E Dotan, ...Clinical Cancer Research 24 (12), 2749-2757, 2018442018
2-) New class of biodegradable polymers formed from reactions of an inorganic functional groupJ Yoo, DJ Kuruvilla, SR D’Mello, AK Salem, NB BowdenMacromolecules 45 (5), 2292-2300, 2012302012
3-) Human relaxin‐2 fusion protein treatment prevents and reverses isoproterenol‐induced hypertrophy and fibrosis in mouse heartJ Sun, W Hao, N Fillmore, H Ma, D Springer, ZX Yu, A Sadowska, ...Journal of the American Heart Association 8 (24), e013465, 2019212019
4-) Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densitiesDJ Kuruvilla, JA Widness, D Nalbant, RL Schmidt, DM Mock, G An, ...Pediatric research 81 (6), 905-910, 2017212017
5-) Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene …IN Bruce, A Nami, E Schwetje, ME Pierson, T Rouse, YL Chia, D Kuruvilla, ...The Lancet Rheumatology 3 (2), e101-e110, 2021192021